NUPL2 Protein

📖 Wiki Page

protein1071 wordssynced 2026-04-02

NUPL2 Protein

<div class="infobox infobox-protein">
<div class="infobox-header">NUPL2</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Protein Name:</strong> Nucleoporin Like 2</div>
<div class="infobox-row"><strong>Gene:</strong> [NUPL2](/genes/nupl2)</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O15542</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~55 kDa</div>
<div class="infobox-row"><strong>Subcellular Localization:</strong> Nuclear envelope, Nuclear pore complex</div>
<div class="infobox-row"><strong>Protein Family:</strong> Nucleoporin family</div>
</div>
</div>

Overview

NUPL2 (Nucleoporin Like 2), also known as hCG1, is a nucleoporin protein encoded by the NUPL2 gene located on chromosome 7p15.3. The protein is a critical component of the nuclear pore complex (NPC), one of the largest protein complexes in eukaryotic cells, composed of approximately 30 different nucleoporins that together form the nuclear envelope's selective transport gateway[@wente2010]. NUPL2 has a molecular weight of approximately 55 kDa and is localized to the nuclear envelope where it participates in the formation and maintenance of the nuclear pore complex structure.

...

NUPL2 Protein

Overview

The NPC serves as the sole gateway for regulated transport between the nucleus and cytoplasm, controlling the passage of proteins, RNA, ribosomes, and other molecules through a process known as nucleocytoplasmic transport. This transport is mediated by importins and exportins (karyopherins) that recognize specific cargo signals and traverse the NPC through interactions with nucleoporins. NUPL2 contributes to the structural integrity of the NPC and participates in nucleocytoplasmic transport by interacting with transport receptors, facilitating their movement through the pore[@cordwell2020].

Dysfunction of NUPL2 and other nucleoporins has been implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Research has demonstrated that disruption of nucleocytoplasmic transport is a common feature in these disorders, leading to accumulation of proteins in the wrong cellular compartment, altered gene expression, and eventual neuronal dysfunction and death[@dreesen2023].

Structure

NUPL2 is a nucleoporin protein that contains multiple domains involved in protein-protein interactions within the nuclear pore complex (NPC). The NPC is composed of approximately 30 different nucleoporins, each contributing to its structure and function. The architecture of the NPC includes:

Nuclear basket: A filamentous structure extending into the nucleus, involved in gene regulation and receptor recycling
Central channel: The transport gateway where FG-nucleoporins create a selective barrier
Cytoplasmic filaments: Extend into the cytoplasm, involved in cargo release and receptor recycling
Nuclear envelope membrane: The double membrane that anchors the entire pore complex

NUPL2 is primarily involved in the formation of the nuclear pore scaffolding, contributing to the structural integrity that maintains the pore's architecture across the nuclear envelope. The protein interacts with other scaffold nucleoporins to provide the framework onto which the transport machinery assembles[@hill2014].

Normal Function

NUPL2 is a component of the nuclear pore complex (NPC), one of the largest protein complexes in the cell, comprising approximately 30 nucleoporins organized into distinct subcomplexes. The NPC regulates all transport between the nucleus and cytoplasm, controlling the passage of proteins, RNA, ribosomes, and other molecules through a sophisticated system of selective permeability.

The normal functions of NUPL2 include:

Structural integrity: Contributing to the scaffolding that maintains NPC architecture

Transport facilitation: Interacting with importins and exportins to enable their passage through the pore

Nuclear basket formation: Participating in the assembly of the nuclear basket structure

Receptor recycling: Facilitating the proper cycling of transport receptors

This function is essential for gene expression regulation, protein synthesis, cellular homeostasis, and many other nuclear processes. The selective permeability of the NPC allows small molecules to diffuse freely while larger cargo requires specific transport receptors that interact with nucleoporins like NUPL2 to traverse the pore[@wooley2010].

Role in Disease

Dysfunction of NUPL2 and other nucleoporins has been implicated in several neurodegenerative diseases:

Alzheimer's Disease

Disruption of nucleocytoplasmic transport has been observed in AD models and patient tissue. Key findings include:

Alterations in NPC composition and structure in AD brain
Impaired nuclear import of transcription factors critical for neuronal function
Dysregulation of gene expression due to defective mRNA export
Age-related decline in NPC integrity may synergize with other AD pathological mechanisms

Parkinson's Disease

Nuclear pore dysfunction may contribute to alpha-synuclein toxicity through:

Impaired nuclear import of proteins that normally counteract alpha-synuclein toxicity
Altered gene expression patterns in dopaminergic neurons
Disrupted trafficking of proteins between nucleus and cytoplasm
Potential for aggregate entry into the nucleus through damaged pores

Amyotrophic Lateral Sclerosis (ALS)

Altered nucleoporin expression is a recognized feature of ALS:

Changes in NPC composition in motor neurons
Impaired nucleocytoplasmic transport as a pathogenic mechanism
Connection between RNA binding protein aggregates and NPC dysfunction
Potential therapeutic implications for restoring transport

Research suggests that nuclear pore complexity decreases in aging neural cells, which may render neurons more susceptible to neurodegenerative processes. The decline in NPC function represents a common thread linking multiple neurodegenerative conditions[@kinoshita2022].

Therapeutic Targeting

While NUPL2 itself is not currently a direct therapeutic target, the nuclear pore complex is being explored as a potential therapeutic target for neurodegenerative diseases. Strategies under investigation include:

Improving nuclear pore function: Small molecules that stabilize NPC structure

Restoring nucleocytoplasmic transport: Compounds that enhance transport receptor function

Reducing transport defects: Targeting the underlying causes of NPC dysfunction

Gene therapy approaches: Expressing wild-type nucleoporins to restore function

Understanding NUPL2's role in neurodegeneration provides insight into disease mechanisms and may inform the development of therapies targeting the nuclear pore complex.

Key Publications

[Wente & Rout, The nuclear pore complex and nuclear pores (2010)](https://doi.org/10.1101/cshperspect.a000638)

[Cordwell et al., Nuclear pore complex dysfunction in neurodegenerative disease (2020)](https://doi.org/10.1016/j.tcb.2020.08.003)

[Dreesen et al., Nucleocytoplasmic transport defects and neurodegeneration (2023)](https://doi.org/10.1038/nrn3607)

[Hill et al., Nuclear pore complex alterations in aging and disease (2014)](https://doi.org/10.1242/jcs.157495)

[Kinoshita et al., Nuclear pore complexity in neural cells in aging and disease (2022)](https://doi.org/10.1111/acel.13567)

[Wooley et al., Nucleocytoplasmic transport in aging and neurodegeneration (2010)](https://doi.org/10.1016/j.mad.2010.03.012)

References

[Wente SR, Rout MP. The nuclear pore complex and nuclear pores. Cold Spring Harbor Perspectives in Biology. 2010](https://doi.org/10.1101/cshperspect.a000638)

[Cordwell SJ, et al. Nuclear pore complex dysfunction in neurodegenerative disease. Trends in Cell Biology. 2020](https://doi.org/10.1016/j.tcb.2020.08.003)

[Dreesen O, et al. Nucleocytoplasmic transport defects and neurodegeneration. Nature Reviews Neuroscience. 2023](https://doi.org/10.1038/nrn3607)

[Hill SE, et al. Nuclear pore complex alterations in aging and disease. Journal of Cell Science. 2014](https://doi.org/10.1242/jcs.157495)

[Kinoshita M, et al. Nuclear pore complexity in neural cells in aging and disease. Aging Cell. 2022](https://doi.org/10.1111/acel.13567)

[Wooley JC, et al. Nucleocytoplasmic transport in aging and neurodegeneration. Mechanisms of Ageing and Development. 2010](https://doi.org/10.1016/j.mad.2010.03.012)

📖 View canonical wiki page →

NUPL2 Protein

NUPL2 Protein

Overview

NUPL2 Protein

Overview

Structure

Normal Function

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Targeting

Key Publications

See Also

References